Abiopharma

🔍 Romano Gianluca (Executive)

Company: Seagate Technology Holdings plc (STX)

Report Date: 2026-06-11

Detailed Transactions and Holdings:

• Acquired 1,695 shares of Ordinary Shares (Direct)
  Date: 2026-06-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 43,763.50 | transaction_form_type: 4
• Sold 903 shares of Ordinary Shares at $880.1873 per share (Direct)
  Date: 2026-06-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 42,860.25 | transaction_form_type: 4
• Sold 1,695 shares of Restricted Share Unit (Derivative)
  Date: 2026-06-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 8,475.00 | transaction_form_type: 4 | Footnotes: F1, F1

Footnotes:

• F1: Consists of a grant of restricted share unit awarded to the reporting person under the Seagate Technology Holdings plc 2022 Equity Incentive Plan. Subject to the Reporting Person's continuous employment, one-quarter vested starting on September 11, 2024 and then in equal quarterly installments over the following three years for a total vesting period of four years.